
Tessenderlo Group NV (TESB) | Financial Analysis & Statements
Tessenderlo Group NV | Large-cap | Basic Materials
Tessenderlo Group NV | Large-cap | Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2013Income Metrics
Revenue
346.1M
Gross Profit
61.2M
17.68%
Operating Income
3.1M
0.90%
Net Income
-17.8M
-5.14%
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
1.0B
Shareholders Equity
1.9B
Debt to Equity
0.53
Cash Flow Metrics
Operating Cash Flow
15.3M
Free Cash Flow
-12.9M
Revenue & Profitability Trend
Tessenderlo Group NV Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.6B | 2.9B | 2.6B | 2.1B | 1.7B |
Cost of Goods Sold | 2.1B | 2.4B | 1.9B | 1.5B | 1.3B |
Gross Profit | 513.1M | 558.2M | 668.0M | 547.0M | 481.5M |
Gross Margin % | 19.4% | 19.1% | 25.8% | 26.3% | 27.7% |
Operating Expenses | |||||
Research & Development | 28.8M | 29.5M | 13.1M | 10.4M | 11.9M |
Selling, General & Administrative | 419.6M | 406.2M | 349.1M | 306.6M | 276.4M |
Other Operating Expenses | 10.1M | 4.5M | -8.1M | 1.4M | 12.2M |
Total Operating Expenses | 458.5M | 440.2M | 354.1M | 318.4M | 300.5M |
Operating Income | 58.7M | 119.5M | 313.7M | 227.3M | 179.5M |
Operating Margin % | 2.2% | 4.1% | 12.1% | 10.9% | 10.3% |
Non-Operating Items | |||||
Interest Income | 10.1M | 9.8M | 900.0K | 400.0K | 300.0K |
Interest Expense | 10.0M | 10.1M | 8.5M | 9.7M | 10.1M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 46.6M | 116.4M | 289.2M | 230.9M | 133.6M |
Income Tax | 2.6M | 2.0M | 62.4M | 42.6M | 34.9M |
Effective Tax Rate % | 5.6% | 1.7% | 21.6% | 18.4% | 26.1% |
Net Income | 44.0M | 114.4M | 226.8M | 188.3M | 98.6M |
Net Margin % | 1.7% | 3.9% | 8.8% | 9.0% | 5.7% |
Key Metrics | |||||
EBITDA | 306.2M | 313.1M | 514.4M | 373.2M | 276.4M |
EPS (Basic) | €0.70 | €1.74 | €5.26 | €4.36 | €2.30 |
EPS (Diluted) | €0.70 | €1.74 | €5.26 | €4.36 | €2.30 |
Basic Shares Outstanding | 61467934 | 63057142 | 43094553 | 43022979 | 43121077 |
Diluted Shares Outstanding | 61467934 | 63057142 | 43094553 | 43022979 | 43121077 |
Income Statement Trend
Tessenderlo Group NV Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 182.4M | 177.0M | 156.1M | 320.3M | 230.1M |
Short-term Investments | 70.0M | - | - | 10.0M | 20.0M |
Accounts Receivable | 372.2M | 388.7M | 373.4M | 332.4M | 237.4M |
Inventory | 560.3M | 604.5M | 567.0M | 393.4M | 332.3M |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 1.3B | 1.3B | 1.2B | 1.1B | 860.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 704.5M | 670.9M | 570.9M | 536.8M | 511.3M |
Goodwill | 393.8M | 350.5M | 171.2M | 173.8M | 202.5M |
Intangible Assets | 244.2M | 286.9M | 107.0M | 109.2M | 135.7M |
Long-term Investments | 1.1M | 300.0K | 0 | - | - |
Other Non-Current Assets | -100.0K | - | -100.0K | -100.0K | -200.0K |
Total Non-Current Assets | 1.7B | 1.7B | 1.1B | 1.1B | 1.1B |
Total Assets | 2.9B | 2.9B | 2.3B | 2.2B | 2.0B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 279.5M | 260.3M | 272.8M | 247.9M | 176.7M |
Short-term Debt | 123.3M | 61.6M | 56.2M | 211.5M | 66.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 599.7M | 490.2M | 453.5M | 597.9M | 361.8M |
Non-Current Liabilities | |||||
Long-term Debt | 134.1M | 175.3M | 209.3M | 193.6M | 385.1M |
Deferred Tax Liabilities | 114.1M | 126.5M | 56.3M | 65.4M | 66.3M |
Other Non-Current Liabilities | - | -400.0K | 100.0K | -100.0K | -100.0K |
Total Non-Current Liabilities | 422.7M | 475.7M | 444.1M | 477.8M | 700.5M |
Total Liabilities | 1.0B | 965.9M | 897.6M | 1.1B | 1.1B |
Equity | |||||
Common Stock | 428.3M | 428.3M | 216.2M | 216.2M | 216.2M |
Retained Earnings | - | - | - | - | - |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.9B | 1.9B | 1.4B | 1.1B | 904.1M |
Key Metrics | |||||
Total Debt | 257.4M | 236.9M | 265.5M | 405.1M | 451.3M |
Working Capital | 667.8M | 767.5M | 699.9M | 503.7M | 498.9M |
Balance Sheet Composition
Tessenderlo Group NV Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 44.0M | 114.4M | 226.8M | 188.3M | 98.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 83.8M | 84.6M | -196.9M | -145.2M | -29.7M |
Operating Cash Flow | 93.3M | 205.5M | 29.9M | 40.9M | 103.8M |
Investing Activities | |||||
Capital Expenditures | -178.5M | -176.9M | -111.2M | -88.7M | -93.7M |
Acquisitions | -60.7M | 40.2M | -42.1M | 0 | -7.8M |
Investment Purchases | 0 | -70.0M | -50.0M | -40.0M | -20.0M |
Investment Sales | 7.2M | 130.7M | 10.0M | 50.0M | 0 |
Investing Cash Flow | -232.0M | -76.1M | -193.4M | -78.7M | -121.5M |
Financing Activities | |||||
Share Repurchases | -47.3M | -32.4M | -600.0K | 0 | -4.2M |
Dividends Paid | -54.0M | -39.9M | - | - | - |
Debt Issuance | 65.0M | 5.8M | 60.0M | 1.3M | 7.5M |
Debt Repayment | -39.8M | -43.7M | -198.0M | -48.7M | -47.2M |
Financing Cash Flow | -61.8M | -88.4M | -135.6M | -42.8M | -43.2M |
Free Cash Flow | 152.6M | 40.7M | 86.4M | 152.1M | 182.1M |
Net Change in Cash | -200.5M | 41.0M | -299.1M | -80.6M | -60.9M |
Cash Flow Trend
Tessenderlo Group NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.21
Forward P/E
14.26
Price to Book
0.86
Price to Sales
0.57
PEG Ratio
14.26
Profitability Ratios
Profit Margin
-0.99%
Operating Margin
3.44%
Return on Equity
-1.40%
Return on Assets
0.87%
Financial Health
Current Ratio
1.94
Debt to Equity
14.34
Beta
0.40
Per Share Data
EPS (TTM)
€-0.43
Book Value per Share
€30.09
Revenue per Share
€45.37
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
tesb | 1.5B | 37.21 | 0.86 | -1.40% | -0.99% | 14.34 |
Biotalys N.V | 168.5M | - | 6.04 | -49.60% | 0.00% | 17.56 |
Syneos Health | 7.4B | 377.86 | 1.19 | -1.20% | -1.30% | 45.57 |
Azelis Group NV | 3.1B | 17.67 | 1.12 | 6.41% | 4.01% | 77.22 |
Solvay SA | 2.9B | 20.70 | 2.49 | 11.13% | 2.81% | 185.12 |
Titan Cement | 2.7B | 13.11 | 1.51 | 12.28% | 7.88% | 36.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.